Dual stimuli-responsive release of aptamer AS1411 decorated erlotinib loaded chitosan nanoparticles for non-small-cell lung carcinoma therapy-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Dual stimuli-responsive release of aptamer AS1411 decorated erlotinib loaded chitosan nanoparticles for non-small-cell lung carcinoma therapy

Published:2020-10 Issue: Volume:245 Page:116407
ISSN:0144-8617
Container-title:Carbohydrate Polymers
language:en
Short-container-title:Carbohydrate Polymers

Author:

Saravanakumar Kandasamy,Sathiyaseelan Anbazhagan,Mariadoss Arokia Vijaya Anand,Jeevithan Elango,Hu Xiaowen,Shin Sukjin,Wang Myeong-Hyeon

Funder

Korea Research Fellowship Program

National Research Foundation of Korea

Ministry of Science, ICT and Future Planning

Publisher

Elsevier BV

Subject

Materials Chemistry,Polymers and Plastics,Organic Chemistry

Reference54 articles.

1. Targeting the extrinsic apoptotic pathway in cancer: Lessons learned and future directions;Ashkenazi;The Journal of Clinical Investigation,2015

2. Chitosan-based drug delivery systems;Bernkop-Schnürch;European Journal of Pharmaceutics and Biopharmaceutics,2012

3. Erlotinib-induced dermatologic side-effects;Bovenschen;International Journal of Dermatology,2009

4. Novel hydrophilic chitosan-polyethylene oxide nanoparticles as protein carriers;Calvo;Journal of Applied Polymer Science,1997

5. Treatment of non–small-cell lung cancer with erlotinib or gefitinib;Cataldo;New England Journal of Medicine,2011

Cited by 51 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Revolutionizing Lung Cancer Treatment: Nanotechnology-Driven Advances in Targeted Drug Delivery and Novel Therapeutic Strategies;Journal of Drug Delivery Science and Technology;2024-09

2. Current advance of nanotechnology in diagnosis and treatment for malignant tumors;Signal Transduction and Targeted Therapy;2024-08-12

3. Exploration of Nanomedicine-Based Dry Powder Inhalation Formulation Co-Loaded with Erlotinib and Curcumin for Treatment of Non-Small Cell Lung Cancer;Nano LIFE;2024-07-31

4. Harnessing nanotechnology for enhanced delivery of erlotinib: a dynamic duo in cancer treatment;Beni-Suef University Journal of Basic and Applied Sciences;2024-07-26

5. Facile engineering of aptamer-coupled silk fibroin encapsulated myogenic gold nanocomposites: investigation of antiproliferative activity and apoptosis induction;Biotechnology Letters;2024-04-27

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3